Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002614 |
---|---|
Receipt number | R000003190 |
Scientific Title | A Phase II study of Glypican-3(GPC3) peptide vaccine as adjuvant treatment for Hepatocellular carcinoma(HCC) after Surgical resection or Radiofrequency ablation(RFA) |
Date of disclosure of the study information | 2009/10/11 |
Last modified on | 2014/10/14 09:10:35 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/10/11 18:33:23 | ||
2 | Update | 2010/04/12 07:52:36 | Organization Organization Organization Institute Organization1 |
|
3 | Update | 2012/10/11 09:37:07 | Division name Division name Division name Division name Division name Division name Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2012/10/11 09:39:35 | Last follow-up date |
|
5 | Update | 2013/04/11 09:59:54 | Recruitment status |
|
6 | Update | 2013/10/15 12:27:33 | Email |
|
7 | Update | 2014/10/14 09:10:35 | Recruitment status Last follow-up date |